Satish Medakkar: The Importance of Early Recognition in Atypical Hemolytic Uremic Syndrome
Satish Medakkar, Head of Advanced Analytics and Data Science at Alexion Pharmaceuticals, Inc., shared Alexion Pharmaceuticals, Inc.‘s post on LinkedIn, adding:
“Atypical hemolytic uremic syndrome (or aHUS), also known as complement-mediated thrombotic microangiopathy (or CM-TMA), is an ultra-rare condition where parts of your immune system mistakenly attack the cells lining your blood vessels.
This results in small blood clots, which can reduce blood flow to your kidneys and other vital organs.
Healthcare providers usually diagnose aHUS when you have three conditions together: Microangiopathic hemolytic anemia, Thrombocytopenia, and acute kidney injury.
This combination of conditions makes aHUS difficult to diagnose because the episodes can be triggered by other health conditions.”
Alexion Pharmaceuticals, Inc. shared a post on LinkedIn:
“Timely and accurate diagnosis is critical for people living with atypical haemolytic uraemic syndrome (aHUS), an ultra-rare, rapidly progressive disease that may result in severe organ damage and death.
aHUS is a type of thrombotic microangiopathy (TMA) that is caused by dysregulation of the complement immune system.
aHUS often presents suddenly and frequently develops into a chronic condition with relapses.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments